Camena Bioscience
Cambridge
About Camena Bioscience
Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existing Phosphoramidite synthesis technology. Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Last round: Series Unknown (Sep 2025)
- Website: camenabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/camena-bioscience-76842 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.